MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Lung Function and the Risk of Parkinson’s Disease: A Population-based Cohort Study

    JY. Liu, SC. Wang, XT. Zheng, SR. Zhang, QR. Jiang, CY. Li, HF. Shang (Chengdu, Sichuan, China)

    Objective: The study aims to explore the association between lung function and the risk to develop PD. Background: Some researchers have noted a faster decline…
  • 2025 International Congress

    Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry

    A. Rincon, C. Pantoja, J. Torres, C. Tamayo, D. Rosselli (Bogotá, Colombia)

    Objective: Conduct a descriptive analysis of the Colombian Parkinson’s disease population and its comorbidities using data from the Colombian Ministry of Health.Estimate the prevalence and…
  • 2025 International Congress

    Levodopa response in pathology-confirmed Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy

    V. Arca, J. Jurkeviciene, S. Wrigley, P. Cullinane, J. Parmera, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

    Objective: to describe the rate of levodopa response, phenotypical characteristics, prognostic implications and pathological features in a large cohort of patients with pathology-confirmed Parkinson’s disease…
  • 2025 International Congress

    The Impact of Freezing of Gait on Falls over time in Parkinson’s disease

    A. Madamangalam, V. Lavu, J. Yu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesville, USA)

    Objective: To quantify falls related to Freezing of Gait (FoG) versus unrelated to FoG as Parkinson’s disease progresses. Background: FoG is a debilitating symptom of…
  • 2025 International Congress

    Evaluation of Effects of Levodopa and Subthalamic Nucleus Stimulation (STN-DBS) on Gait using Quantified Timed Up and Go Test in People with Parkinson’s Disease (PD)

    F. Ruggieri, E. Reynolds, C. O'Keeffe, J. Inocentes, M. Kelly, E. Donlon, M. Garvey, N. Austin, C. Fearon, C. Moran, R. Walsh (Dublin, Ireland)

    Objective: This study evaluates effect of medication and stimulation on transfers and gait in people with PD post STN-DBS using an automated, quantitative assessment involving…
  • 2025 International Congress

    Parkinson’s Disease Diagnosed in a Patient with Anti-Musk Positive Myasthenia Gravis: Coincidence? – Case Report and Literature Review

    J. Sánchez León, T. Luise Denicol, C. Matté Dagostini, R. de Castro, A. Hilbig, A. Hoppe, C. Mello Rieder (Porto Alegre, Brazil)

    Objective: To describe a case of a male patient presenting with anti-Musk positive Myasthenia Gravis (MG) and Parkinson's Disease (PD) with an adequate response to…
  • 2025 International Congress

    A Registry for Sleep and Circadian Health Quality in Parkinson’s Disease (ReSCQu-PD)

    J. Cohen (Jacksonville, USA)

    Objective: To characterize sleep-, circadian- and disease-related factors contributing to daytime sleepiness in a cohort of people with Parkinson’s Disease (PwPD). Background: Excessive daytime sleepiness…
  • 2025 International Congress

    PINK1 activation improves outcomes in the UQCRC1 models of Parkinson’s disease

    JL. Li, CC. Chan, CH. Lin (New Taipei City, Taiwan)

    Objective: To investigate the role of chronic oxidative phosphorylation (OXPHOS) stress in mitophagy and the therapeutic potential of PINK1 activation in the UQCRC1 models of…
  • 2025 International Congress

    Profiling Neural Protein Dopaminylation in Parkinson’s disease

    W. Chen, I. Maze (NEW YORK, USA)

    Objective: The hallmark of Parkinson’s Disease is motor dysfunction from the decline in dopaminergic cells in the substantia nigra (SN), leading to the development of…
  • 2025 International Congress

    Effect of Aβ on α-synuclein propagation

    Y. Narumiya, E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, T. Maki, T. Saito, R. Takahashi, R. Matsumoto, H. Yamakado (Nagoya, Japan)

    Objective: To investigate how amyloid-beta (Aβ) pathology affects α-synuclein (α-syn) propagation. Background: Lewy bodies, the pathological hallmark of Parkinson’s disease and dementia with Lewy bodies,…
  • « Previous Page
  • 1
  • …
  • 201
  • 202
  • 203
  • 204
  • 205
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley